Georgiamune
Manufacturing · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
942 Clopper Rd, Gaithersburg, Maryland, ...Website
www.georgiamune.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Georgiamune
Georgiamune is a clinical stage biotechnology company focused on reprogramming immune signaling pathways to redirect the immune system to fight diseases.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Georgiamune your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Georgiamune, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Georgiamune has new funding data
Congratulate Masked Content for being promoted to Masked Content at Georgiamune
Click to see if Georgiamune had a recent Job posting/layoffs
Check if Georgiamune has recently received funding, and reach out quickly before it becomes old news!
Check out if Georgiamune is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Georgiamune recently announced quarterly report
Product Launch: Get notified when Georgiamune launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Georgiamune
Compare insights from companies similar to Georgiamune, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Georgiamune
<$5M
11-50
Private
$75M
-
N/A
Company Profile Activity
Activity Insights
Georgiamune is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Georgiamune is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Georgiamune.
Georgiamune financials insights
Gather financial insights about Georgiamune, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series A
$75M
Georgiamune Tech Stack
A closer look at the technologies used by Georgiamune
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Open Position
Open Position
Left Company
Executive Move
Left Company
Executive Move
Georgiamune News & Media
Georgiamune Announces First Participant Dosed in First-In-Class Phase 1 Healthy Volunteers Trial of GIM-407
Georgiamune continues biotech innovation streak with first autoimmune disease-focused program based on novel biology Georgiamune continues biotech innovation streak with first autoimmune disease-focused program based on novel biologyGeorgiamune Announces First Patient Dosed in A First-In-Class Phase 1 Cancer Treatment Trial of GIM-531
GAITHERSBURG, Md., July 30, 2024 (GLOBE NEWSWIRE) -- Today, Georgiamune Inc., a privately held, clinical-stage biotechnology company, announced that the first patient has been dosed with GIM-531 in a first-in-human, phase 1 clinical trial for the treatment of advanced cancer patients. GIM-531 development focuses on indications that are currently not addressed with existing or available immunotherapies including anti-PD-1 antibodies. It is an oral therapy that is a first-in-class selective T reguUPDATE -- Georgiamune Expands Cancer Treatment Pipeline with Two Novel Drugs Within Five Months of Launch
Georgiamune receives U.S. FDA clearance for GIM-531 and continues to enroll patients in clinical trial testing for GIM-122 Georgiamune receives U.S. FDA clearance for GIM-531 and continues to enroll patients in clinical trial testing for GIM-122Georgiamune Expands Cancer Treatment Pipeline with Two Novel Drugs Within Five Months of Launch
Georgiamune receives U.S. FDA clearance for GIM-531 and begins phase II of clinical trial testing for GIM-122 Georgiamune receives U.S. FDA clearance for GIM-531 and begins phase II of clinical trial testing for GIM-122
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Georgiamune
Sign Up For FreeTo access detailed company insights
Georgiamune is a clinical stage biotechnology company focused on reprogramming immune signaling pathways to redirect the immune system to fight diseases.... Read More
